Previous close | 4.5000 |
Open | 4.3000 |
Bid | 4.1000 |
Ask | 4.2000 |
Strike | 25.00 |
Expiry date | 2025-01-17 |
Day's range | 4.1200 - 4.3000 |
Contract range | N/A |
Volume | |
Open interest | 31.63k |
Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
Pfizer Inc. ( NYSE:PFE ) just released its first-quarter report and things are looking bullish. It was overall a...
As the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a Citi analyst who hasn’t recommended the stock in over a decade. But Andrew Baum has something Pfizer needs: oncology expertise.